Blinatumomab followed by POMP maintenance shows effectiveness for newly diagnosed patients
Novel three-drug regimen used to manage life-threatening developments
Dr. Mikkael Sekeres in his latest New York Times column
Mutational pattern in MDS is not random, study finds
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Reflections on treating a patient with cognitive differences
A Cleveland Clinic oncologist’s book reflects on patients’ and physicians’ shared journeys
Lower toxicity than conventional chemo
Response rates as good as or better than other therapies
Groundbreaking study paves way for targeted therapy
Study shows risk of overtreating patients